OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
51 hedge funds and large institutions have $17.6M invested in Orexigen Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less capital invested
Capital invested by funds: $23.6M → $17.6M (-$5.94M)
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
Holders
51
Holding in Top 10
1
Calls
$1.02M
Puts
$836K
Top Buyers
| 1 | +$132K | |
| 2 | +$61K | |
| 3 | +$57K | |
| 4 |
Citigroup
New York
|
+$32.1K |
| 5 |
BlackRock
New York
|
+$17.7K |
Top Sellers
| 1 | -$874K | |
| 2 | -$861K | |
| 3 | -$405K | |
| 4 |
JG
Jefferies Group
New York
|
-$86K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$85.6K |